Development and evaluation of porous chitosan nanoparticles for treatment of enterotoxigenic escherichia coli infection

Journal of Biomedical Nanotechnology

Volumn 9, Issue 1, 2013, Pages 107-114

  Khan, Mohammed S ^a   Vishakante, Gowda D ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Enterotoxigenic Escherichia Coli; Porous Nanoparticles; Spray Drying; Vaccination

Indexed keywords

CHITOSAN NANOPARTICLES; DRUG LOADED NANOPARTICLE; ENTEROTOXIGENIC ESCHERICHIA COLI; GASTROINTESTINAL TRACT; MUCOSAL IMMUNE RESPONSE; POLYDISPERSITY INDICES; POROUS NANOPARTICLES; VACCINATION;

ANIMALS; ANTIGENS; CHITOSAN; ESCHERICHIA COLI; LOSSES; NANOPARTICLES; SPRAY DRYING; VACCINES; ZETA POTENTIAL;

IMMUNE SYSTEM;

ANTIGEN; CHITOSAN; CHITOSAN NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; ENTEROTOXIC ESCHERICHIA COLI INFECTION; ENTEROTOXIGENIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI INFECTION; FIMBRIA; FREEZE DRYING; GASTROINTESTINAL TRACT; IMMUNE RESPONSE; IN VITRO STUDY; INOCULATION; NONHUMAN; POLYDISPERSITY INDEX; SCANNING ELECTRON MICROSCOPY; SMALL INTESTINE; SPRAY DRYING; TRANSMISSION ELECTRON MICROSCOPY; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY SPECIFICITY; BACTERIAL ADHESION; BACTERIAL PROTEINS; CHITOSAN; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROCYTES; ENTEROTOXIGENIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; FIMBRIAE, BACTERIAL; HUMANS; IMMUNIZATION; NANOPARTICLES; PARTICLE SIZE; POROSITY; RECEPTORS, IMMUNOLOGIC; SUS SCROFA;

EID: 84876545531     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2013.1471     Document Type: Article

References (36)

1. M. Kosek, C. Bern, and R. L. Guerrant, The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000. Bull. W.H.O. 81, 197 (2003).
2. J. P. Nataro and J. B. Kaper, Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11, 142 (1998).
3. World health organization, New frontiers in the development of vaccines against enterotoxigenic (ETEC) and enterohaemorrhagic (EHEC) E. Coli infections. Weekly Epidemiol. Rec. 13, 98 (1999).
4. C. DebRoy and C. W. Maddox, Identification of virulence attributes of gastrointestinal Escherichia coli isolates of veterinary significance. Anim. Health Res. Rev. 1, 129 (2001).
5. J. M. Rutter and G. M. Jones, Protection against enteric disease caused by Escherichia coli - a model for vaccination with a virulence determinant? Nature 242, 531 (1973).
6. P. Deprez, V. D. Hende, E. Muylle, and W. Oyaert, The influence of the administration of sow's milk on the postweaning excretion of haemolytic Escherichia coli in the pig. Vet. Res. Commun. 10, 469 (1986).
7. H. W. Moon and T. O. Bunn, Vaccines for preventing enterotoxigenic Escherichia coli infections in farm animals. Vaccine 11, 213 (1993).
8. D. J. Hampson, Postweaning Escherichia coli diarrhoea in pigs. Escherichia Coli in Domestic Animals and Humans, edited by C. L. Gyles, CAB International, Wallingford, Oxon, United Kingdom (1994), p. 177.
9. C. L. Gyles, Escherichia coli enterotoxins. Escherichia Coli in Domestic Animals and Humans, edited by C. L. Gyles, Wallingford, Oxon OX10 8DE, CAB International, UK (1994), pp. 337-64.
10. R. A. Gibbons, R. Sellwood, M. Burrows, and P. A. Hunter, Inheritance of resistance to neonatal Escherichia coli diarrhea in the pig, examination of the genetic system. Theor. Appl. Genet. 81, 65 (1997).
11. J. M. Rutter, M. R. Burrows, R. Sellwood, and R. A. Gibbons, A genetic basis for resistance to enteric disease caused by E. Coli. Nature (London) 257, 135 (1975).
12. F. G. van Zijderveld, A. M. Bemmel, and D. Bakker, The F41 adhesin of enterotoxigenic Escherichia coli: Inhibition of adhesion by monoclonal antibodies. Vet Q. 20, S73 (1998).
13. V. Snoeck, E. Cox, F. Verdonck, J. J. Joensuu, and B. M. Goddeeris, Influence of pH and gastric digestion on antigenicity of F4 fimbriae for oral immunisations. Vet. Microbiol. 98, 45 (2004).
14. H. Q. Mao, K. Roy, V. L. Troung-Le, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August, and K. W. Leong, Chitosan-DNA nanoparticles as gene carriers: Synthesis, characterization and transfection efficiency. J. Control Release 70, 399 (2001).
15. K. A. Janes, P. Calvo, and M. J. Alonso, Polysaccharide colloidal particles as delivery systems for macromolecules. Adv. Drug Deliv. Rev. 47, 83 (2001).
16. M. J. Alonso and A. Sanchez, The potential of chitosan in ocular drug delivery. J. Pharm. Pharmacol. 55, 1451 (2003).
17. O. Jeffrey and H. Sham, Formulation and characterization of spraydried powders containing nanoparticles for aerosol delivery to the lung. Int. J. Pharm. 268, 457 (2004).
18. R. S. Scheila, R. Adriana, G. M. Pohlmann, and S. G. Sílvia, Development of nanocapsule suspensions and nanocapsule spray-dried powders containing melatonin. J. Braz. Chem. Soc. 17, 562 (2006).
19. R. P. Adriana, W. Valeria, M. Omar, P. S. Nádya, and S. G. Sílvia, Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: Development, stability evaluation and nanostructure models. Eur. J. Pharm. Sci. 16, 305 (2002).
20. M. S. Hasegawa, V. S. Komlev, S. M. Barinov, and A. Uchida, High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution. J. Biomed. Mater. Res. Part B: Appl. Biomater. 70, 332 (2003).
21. M. Sivakumar and K. P. Rao, Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres. Biomaterials 23, 3175 (2002).
22. A. E. Burgos, J. C. Belchior, and R. D. Sinisterra, Controlled release of rhodium(II) carboxylates and their association complexes with cyclodextrins from hydroxyapatite matrix. Biomaterials 23, 2519 (2002).
23. M. Itokazum. M. Esakim, K. Yamamoto, T. Tanemori, and T. Kasai, Local drug delivery system using ceramics: Vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block. J. Mat. Sci.: Mat. Med. 10, 249 (1999).
24. A. Lebugle, A. Rodrigues, P. Bonnevialle, J. J. Voigt, P. Canal, and F. Rodriguez, Study of implantable calcium phosphate systems for the slow release of methotrexate. Biomaterials 23, 3517 (2002).
25. D. M. Arm, A. F. Tencer, S. D. Bain, and D. Celino, Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone in growth. Biomaterials 17, 703 (1996).
26. R. Guerra, E. Lima, M. Viniegra, A. Guzman, and V. Lara, Growth of Escherichia coli and Salmonella typhi inhibited by fractal silver nanoparticles supported on zeolites. Microporous Mesoporous Mater. 147, 267 (2012).
27. A. M. Healy, B. F. McDonald, L. Tajber, and O. I. Corrigan, Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethazide. Eur. J. Pharm. Biopharm. 69, 1182 (2008).
28. A. A. C. Jacobs and F. K. Graaf, Production of K88, K99 and F41 fibrillae in relation to growth phase, and a rapid procedure for adhesion purification. FEMS Microbiol. Lett. 26, 15 (1985).
29. K. Weber and M. Osborn, The reliability of molecular weight determinations by dodecyl sulfate polyacrylamide gel electrophoresis. J. Biol. Chem. 244, 4406 (1969).
30. A. K. Erickson, J. A. Willgohs, S. Y. McFarland, D. A. Benfield, and D. H. Francis, Identification of two porcine brush border glycoproteins that bind the K88ac adhesin of Escherichia coli and correlation of these glycoproteins with the adhesive phenotype. Infect. Immun. 60, 983 (1992).
31. N. Huyghebaert, V. Snoeck, A. E. Vermeirea, B. M. Cox, and J. P. Goddeeris, Development of an enteric-coated pellet formulation of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. Eur. J. Pharm. Biopharm. 59, 273 (2005).
32. V. Snoeck, E. Cox, F. Verdonck, J. J. Joensuu, and B. M. Goddeeris, Influence of pH and gastric digestion on antigenicity of F4 fimbriae for oral immunisations. Vet. Microbiol. 98, 45 (2004).
33. V. D. B. Wim, C. Eric, and M. G. Bruno, Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infection and Immunity 520 (1999).
34. T. E. Tarara, J. G. Weers, A. Kabalnov, E. G. Schutt, and L. A. Dellamary, Methods of spray drying pharmaceutical compositions, US 6,565,885 B1 (2003).
35. M. F. Zambaux, F. Bonneauxa, R. Gref, P. Maincent, E. Dellacherieb, M. J. Alonso, P. Labrude, and C. Vigneron, Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method. J. Controlled Release 50, 31 (1998).
36. T. Akansha, G. Ranjana, and A. Shubhini, PLGA nanoparticles of anti tubercular drug, drug loading and release studies of a water in-soluble drug. International Journal of Pharm. Tech. Research 2, 2116 (2010).